Does DURVALUMAB Cause Interstitial lung disease? 430 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 430 reports of Interstitial lung disease have been filed in association with DURVALUMAB (IMFINZI). This represents 2.5% of all adverse event reports for DURVALUMAB.
430
Reports of Interstitial lung disease with DURVALUMAB
2.5%
of all DURVALUMAB reports
144
Deaths
220
Hospitalizations
How Dangerous Is Interstitial lung disease From DURVALUMAB?
Of the 430 reports, 144 (33.5%) resulted in death, 220 (51.2%) required hospitalization, and 65 (15.1%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
Yes, Interstitial lung disease is listed as a known adverse reaction in the official FDA drug label for DURVALUMAB.
What Other Side Effects Does DURVALUMAB Cause?
Death (2,817)
Malignant neoplasm progression (1,330)
Pneumonitis (827)
Radiation pneumonitis (786)
Pyrexia (573)
Diarrhoea (530)
Pneumonia (453)
Dyspnoea (444)
Off label use (395)
Fatigue (367)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which DURVALUMAB Alternatives Have Lower Interstitial lung disease Risk?
DURVALUMAB vs DUTASTERIDE
DURVALUMAB vs DUTASTERIDE\TAMSULOSIN
DURVALUMAB vs DUVELISIB
DURVALUMAB vs DYDROGESTERONE
DURVALUMAB vs EBASTINE